(Q41060727)

English

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. (English)

1 reference

Europe PubMed Central

26 September 2017

maternal health

0 references

0 references

4

object named as

Gale Smith

1 reference

Europe PubMed Central

26 September 2017

author name string

Gregory M Glenn

1

1 reference

Europe PubMed Central

26 September 2017

Louis F Fries

2

1 reference

Europe PubMed Central

26 September 2017

D Nigel Thomas

3

1 reference

Europe PubMed Central

26 September 2017

Eloi Kpamegan

5

1 reference

Europe PubMed Central

26 September 2017

Hanxin Lu

6

1 reference

Europe PubMed Central

26 September 2017

David Flyer

7

1 reference

Europe PubMed Central

26 September 2017

Dewal Jani

8

1 reference

Europe PubMed Central

26 September 2017

Somia P Hickman

9

1 reference

Europe PubMed Central

26 September 2017

Pedro A Piedra

10

1 reference

Europe PubMed Central

26 September 2017

language of work or name

0 references

publication date

10 August 2015

1 reference

Europe PubMed Central

26 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Infectious Diseases

1 reference

Europe PubMed Central

26 September 2017

213

1 reference

Europe PubMed Central

26 September 2017

3

1 reference

Europe PubMed Central

26 September 2017

411-422

1 reference

Europe PubMed Central

26 September 2017

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Serum antibody decay in adults following natural respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries--a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Effectiveness of maternal influenza immunization in mothers and infants

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

IgG placental transfer in healthy and pathological pregnancies

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Transplacental transport of IgG antibodies to preterm infants: a review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV406

21 January 2018

Identifiers

10.1093/INFDIS/JIV406

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41060727&oldid=1817196402"